NSCLC Stage IV Without EGFR/ALK Mutation
specific3
Centers
3
Active Trials
—
Cancer Funding
Top Centers for NSCLC Stage IV Without EGFR/ALK Mutation(3)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 66.7 |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 66.7 |
| 3 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 66.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →